Detalles de la búsqueda
1.
Fimepinostat (CUDC-907) in patients with relapsed/refractory diffuse large B cell and high-grade B-cell lymphoma: report of a phase 2 trial and exploratory biomarker analyses.
Br J Haematol
; 195(2): 201-209, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34341990
2.
The impact of the introduction of generic aromatase inhibitors on adherence to hormonal therapy over the full course of 5-year treatment for breast cancer.
Cancer
; 126(15): 3417-3425, 2020 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32484941
3.
Phase 1 trial of tivantinib in combination with sorafenib in adult patients with advanced solid tumors.
Invest New Drugs
; 33(1): 159-68, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25294187
4.
Oncology drug development and approval of systemic anticancer therapy by the U.S. Food and Drug Administration.
Oncologist
; 18(1): 104-11, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23263289
5.
VISTA expression and patient selection for immune-based anticancer therapy.
Front Immunol
; 14: 1086102, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36891296
6.
Clinical and research updates on the VISTA immune checkpoint: immuno-oncology themes and highlights.
Front Oncol
; 13: 1225081, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37795437
7.
MG98, a second-generation DNMT1 inhibitor, in the treatment of advanced renal cell carcinoma.
Cancer Invest
; 30(5): 415-21, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22571342
8.
Mocetinostat for relapsed classical Hodgkin's lymphoma: an open-label, single-arm, phase 2 trial.
Lancet Oncol
; 12(13): 1222-8, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22033282
9.
Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancer.
J Hematol Oncol
; 15(1): 70, 2022 05 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35606824
10.
Activation of targetable inflammatory immune signaling is seen in myelodysplastic syndromes with SF3B1 mutations.
Elife
; 112022 08 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36040792
11.
Association between medication adherence and non-drug healthcare utilisation and costs: a retrospective longitudinal cohort study among US women age 65 and older.
BMJ Open
; 11(12): e052146, 2021 12 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34876428
12.
Cost sharing for breast cancer hormone therapy: How do dual eligible patients' copayment impact adherence.
PLoS One
; 16(5): e0250967, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34003865
13.
The First Study Evaluating the Safety of Pre-Surgery Administration of Metformin in Patients with Colorectal and other Gastrointestinal Cancers and Effect on Cancer Stem Cells.
Cancer Med J
; 4(Suppl 4): 1-10, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34368808
14.
The class-I HDAC inhibitor MGCD0103 induces apoptosis in Hodgkin lymphoma cell lines and synergizes with proteasome inhibitors by an HDAC6-independent mechanism.
Br J Haematol
; 151(4): 387-96, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20880107
15.
Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia.
Blood
; 112(4): 981-9, 2008 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18495956
16.
Prospective Evaluation of Effect of Metformin on Activation of AMP-activated Protein Kinase (AMPK) and Disease Control in a Sub-group Analysis of Patients with GI Malignancies.
J Cell Signal
; 1(2): 35-41, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32601620
17.
Phase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemia.
Br J Haematol
; 147(4): 507-14, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19747365
18.
Evaluation of the pharmacodynamic effects of MGCD0103 from preclinical models to human using a novel HDAC enzyme assay.
Clin Cancer Res
; 14(11): 3441-9, 2008 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18519775
19.
A phase I delayed-start, randomized and pharmacodynamic study of metformin and chemotherapy in patients with solid tumors.
Cancer Chemother Pharmacol
; 84(6): 1323-1331, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31583436
20.
Phase I trial of weekly paclitaxel and BMS-214662 in patients with advanced solid tumors.
Clin Cancer Res
; 13(12): 3623-9, 2007 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17510207